tiprankstipranks
Mersana Therapeutics price target lowered to $5 from $6 at Citi
PremiumThe FlyMersana Therapeutics price target lowered to $5 from $6 at Citi
3M ago
Mersana Therapeutics price target lowered to $3 from $4 at Baird
Premium
The Fly
Mersana Therapeutics price target lowered to $3 from $4 at Baird
3M ago
Mersana Therapeutics Releases Updated Corporate Presentation
Premium
Company Announcements
Mersana Therapeutics Releases Updated Corporate Presentation
3M ago
Mersana sees cash, equivalents sufficient to support operating plan into 2026
PremiumThe FlyMersana sees cash, equivalents sufficient to support operating plan into 2026
7M ago
Mersana Therapeutics reports Q1 EPS (16c), consensus (18c)
Premium
The Fly
Mersana Therapeutics reports Q1 EPS (16c), consensus (18c)
7M ago
Mersana Therapeutics upgraded to Neutral from Underweight at JPMorgan
Premium
The Fly
Mersana Therapeutics upgraded to Neutral from Underweight at JPMorgan
8M ago
Bad News for Mersana Therapeutics Stock: This New Risk Has Been Added
PremiumCompany AnnouncementsBad News for Mersana Therapeutics Stock: This New Risk Has Been Added
9M ago
Mersana Therapeutics upgraded to Buy from Neutral at Guggenheim
Premium
The Fly
Mersana Therapeutics upgraded to Buy from Neutral at Guggenheim
9M ago
Mersana Therapeutics upgraded to Buy from Neutral at BTIG
Premium
The Fly
Mersana Therapeutics upgraded to Buy from Neutral at BTIG
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100